Abstract: Tenofovir, an antiretroviral drug known as nucleoside analogue reverse transcriptase inhibitor, was evaluated for its degradation behavior. The study involved optimization of forced degradation study using the design of experiment (DoE) approach and validation of developed stability indicating assay method (SIAM) for tenofovir. Chromatographic separation was achieved on Kromasil C18 column using mixture of methanol and ammonium acetate buffer pH 8.5 as mobile phase in isocratic elution mode. Detection was done using PDA detector. Tenofovir showed degradation at alkali, acid hydrolysis and oxidative condition while it was stable to photolysis and thermal stress condition. The optimization of forced degradation conditions, like hydrolytic and oxidative, was done by application 3 n full factorial designs, which helped to obtain desired drug degradation. The proposed method was successfully validated as per ICH Q2 (R1) guidelines.
Introduction
Stability is the capacity of a drug product to remain within the specifications. It is a prime requirement to ensure its identity, strength, quality and purity. Degradation studies are undertaken to know intrinsic stability of organic compounds. Such testing is an integral part of the drug development program. Tenofovir is a nucleotide adenosine monophosphate derivative which inhibits reverse transcriptase of both HIV and HBV.
Structure of tenofovir
Chemically it is ({[(2R)-1-(6-amino-9H-purin-9-yl) propan-2-yl] oxy} methyl) phosphonic acid. It has molecular formula C9H14N5O4P and molecular weight 287.2123. It is slightly soluble in water, soluble in methanol and very slightly soluble in dichloromethane. It is available as a fixed dose combination product with different antiretroviral drugs (Bennett, 2014; Saag, 2014) .
Literature survey reveals HPLC, LC/MS methods for estimation of tenofovir alone, in combination with other drugs and in human plasma (Divya, 2015; Gandhi, 2015; Vanaja, 2013; Komaroju, 2013 and Yadav, 2009 ). There are few stability indicating assay methods in the literature (Sutar, 2013; Baig, 2015; Devrukhakar, 2012; Anandgaonkar, 2014; Golla, 2016 and Havele, 2012) but there is no report on stability indicating assay method implementing design of experiment approach. Design of Experiment concept is widely used for optimization of formulation batches. DoE approach is beneficial over conventional trial and error approach in order to obtain desired response. It also involves study of interaction of different variables that affect the response (Hanrahan, 2006; Huber, 2013 and Sonawane, 2012 
Materials and Methods
Pure drug tenofovir was obtained as a gift from Mylan Pharmaceuticals (Nashik, India HPLC system (Shimadzu, Kyoto, Japan) comprising of binary pump (LC -20AD), on line degasser, 20 L injection loop, Prominence diode array detector (SPD -M20A) and LC solution software was used.
Preparation of analyte stock solution
An accurately weighed tenofovir (10 mg) was transferred to a 10 mL volumetric flask and dissolved in 5 mL methanol. After drug was dissolved, methanol was added up to the mark to make a solution of 1 mg mL -1 . From the stock solution, working dilutions of 10 -100 µg mL -1 were made in 10mL volumetric flasks by using methanol.
Forced degradation studies
Forced degradation studies were carried out to achieve 5-30% degradation of the drug. Drug was exposed to acid, alkali, oxidation stress for different time interval (0-24 h). The results were obtained by comparing samples subjected to stress treatment with appropriate controls (std. untreated). The % degradation in each case was noted.
The hydrolytic degradations were carried out in acidic, alkaline and neutral conditions. Samples were prepared by taking 1 mL of stock solution of drug (1 mg mL -1 ) and 1mL of hydrolytic agent (0.1N HCl/ 0.01N HCl/ 0.005 N HCl / 0.1N NaOH/ 0.01N NaOH/ 0.001N NaOH / water) in 10 mL volumetric flask. After required exposure, samples were neutralized by using equal strength of acid or alkali which ever was required. Finally, volume was made up to the mark by using Methanol and subjected for HPLC analysis.
Oxidative degradation was carried out by using hydrogen peroxide. Samples were prepared by taking 1 mL of stock solution of drug (1 mg mL -1 ) and 1ml of hydrogen peroxide (3% or 15% or 30%) in 10 mL volumetric flask. After required exposure, samples were diluted up to the mark by using Methanol and subjected for HPLC analysis. Photo degradation of drug was carried out in solid state; drug (10 mg) was kept in sealed glass ampoule and exposed to ICH recommended dose of light (1.2 million lux h and 200 W h/m 2 ) in photo stability chamber. After definite exposure time; solution of drug sample (100 µg mL -1 ) was prepared by using methanol and subjected to HPLC analysis.
Solid drug sample, 10 mg was sealed in glass ampoules and exposed to dry heat in hot air oven for 100ºC for definite time interval and another was kept as control at room temperature. After required exposure two separate solutions were prepared by weighing appropriate amount of samples exposed to thermal stress and control to produce concentration of 100 µg mL -1 and injected separately into HPLC.
Development and validation of Stability Indicating Assay Method (SIAM)
Chromatographic separation studies were carried out on the working standard solution of drug tenofovir (100 μg mL -1 ). Initially, reversed phase analytical column (C18) was tested by carrying out trials with methanol, water, acetonitrile, potassium dihydrogen phosphate and ammonium acetate buffer in various proportions. Based on the results obtained from screening studies and from literature survey, ammonium acetate buffer and methanol was used in various proportions, molarity and pH to obtain the desired system suitability parameters. After doing several trials using different mobile phase combinations and column following conditions were optimized. Both retention time and peak shape was found as desired for analysis. Under these conditions, retention time of an analyte was found to be 4.94 min with tailing factor 1.04. Hence, this method was selected for further studies. Inter day precision of the method was evaluated at three concentration levels viz. 20, 40 and 60 µg mL -1 . Samples were prepared and injected in triplicate on three consecutive days. In each case peak area was noted; standard deviation (SD) was calculated to determine % RSD.
For intra-day precision, sets of three replicates of drug concentrations at 20, 40 and 60 µg mL -1 ) were analyzed on the same day in same laboratory at morning, afternoon and evening. Precision of the method was evaluated in the similar manner as above, by calculating % RSD.
Recovery of the method was determined by employing standard addition method. The standard of known concentration was spiked at 80, 100 and 120 µg mL -1 in degradants mixture (acid, alkali, photo, neutral, and oxidation degradants) and percent recovery of drug was calculated. Three replicates of each concentration level were analyzed.
LOD was calculated by using following formula: 3.3 σ LOD = S LOQ was calculated by using following formula:
10 σ LOQ = S Where σ = Standard deviation of the Y intercept S = Slope of the calibration curve Optimization of forced degradation conditions The stress studies were optimized to get % degradation in desired range by using Design Expert software 10 in which 3 2 factorial design was applied by considering strength and time as independent factors and % degradation as response. After performing above trials, data of % degradation was obtained and inserted in the design matrix. Design was analyzed to generate response surface designs, equations describing analysis of variance (ANOVA).
Results and Discussion

Forced degradation behavior of tenofovir
The drug solution was treated with 0.005N HCl and kept at room temperature for 1 h the drug underwent acid hydrolysis and produced three degradation products which were eluted at 2.54, 2.93, 3.13 min as shown in figure 2 . The drug degraded significantly under alkaline hydrolytic condition, drug solution was treated with 0.001N NaOH and kept at room temperature for 1h. Degradation was observed along with three degradants at 2.53, 2.93 and 3.74 min ( figure  3 ). Upon oxidative degradation with 3% hydrogen peroxide at room temperature for 1h and neutral hydrolysis, one degradant is observed at 2.93min as shown in figure 4 and 5. Drug was exposed to ICH recommended dose of light (1.2million lux h and 200W h/m 2 ) in photo stability chamber. No degradants were observed. Hence, the drug is considered as photo stable. Upon thermal degradation, the HPLC analysis did not show significant reduction in the peak area of drug as compared to control (figure 6). No additional peak other than peak for tenofovir was observed indicating that tenofovir is stable to dry heat. As factor A (Strength) and factor B are having positive sign, it shows its direct relation with % degradation in acidic stress. Model is quadratic. Values of "Prob > F" (pvalue) less than 0.0500 indicates that model terms are significant. The Model F-value of 251.73 also implies that the model is significant and there is only a 0.04% chance that an F-value this large could occur due to noise. The "Pred R-Squared" of 0.9493 is in reasonable agreement with the "Adj RSquared" of 0.9937; i.e. the difference is less than 0.2 indicate model terms are significant. Response surface graph is shown in figure 7 . sign, shows direct effect on % degradation, while interaction between A&B has negative effect. These effects can be well interpreted with the help of response surface 3D graphs ( Figure 8 ).
Optimization of Forced degradation studies
Quadratic model was suggested by the software. The Model F-value of 1687.09 implies the model is significant. There is only a 0.01% chance that an F-value this large could occur due to noise. Values of "P> F" less than 0.0500 indicate model terms are significant, r 2 value was 0.9996. 
Desirability
In the stress study, the response i.e.; % degradation is usually desired to be in the range of 5-30 %, so it was set as desirability range, A list of solutions was displayed by software indicating various strength and exposure time. Few trials were further practically performed and prediction error was calculated as shown in table 5. Validation of the developed stabilityindicating method Linearity of tenofovir was observed at 20, 40, 60, 80, 100 and 120 µg mL -1 . The equation obtained for regression was y = 1472x+135354. Correlation coefficient (r 2 ) was found to be 0.999. The result showed that an excellent correlation exists between response factor and concentration of drug within concentration range. It was found that the precision results were found satisfactory with respect to % Relative standard deviation (% RSD) for all levels which were within limit (NMT than 2). The developed method was precise for determination of Tenofovir. The mixture of stressed sample was spiked with the drug concentrations of 80, 100 and 120 µg mL -1 . The % mean recovery of Tenofovir was found to be 98.65 %. The result was found satisfactory as % recovery values were within accepted range (98% to 102%).
As per ICH guideline, small but deliberate variations, by altering the pH, wavelength range or flow rate were made to check the capacity of the method. The method was found to be unaffected by changing the pH. It also does not show any significant changes due to alteration of flow rate and wavelength range. The method was found to be unaffected by changing the wavelength, flow rate and pH. As the % RSD was well within the limit (NMT 2.0) developed method was found to be robust. Limit of detection and limit of quantification were determined by using standard deviation of response of the calibration curve. The standard deviation of y-intercept and slope of the calibration curves were used to calculate the LOD and LOQ. Mean precision (mean %RSD) 0.58% 3.
Mean accuracy (%) 98.66%
4.
Robustness (mean % RSD) 1.19 5.
LOD (µg/mL) 0.463 6.
LOQ(µg/mL) 1.405
Conclusion
Stability indicating RP-HPLC method was developed and validated for tenofovir. The method was able to separate tenofovir from its degradation products; it can be used for determination of tenofovir from bulk and stability samples. Forced degradation studies for tenofovir were carried out at different stress conditions as per ICH requirements for hydrolysis, oxidation, thermal and photolytic degradation. Tenofovir was susceptible to acid hydrolysis, alkali hydrolysis and oxidation, while it was stable to thermal and photolytic degradation.
Three degradation products were formed under acid and alkali hydrolysis stress each, whereas one degradation product was formed under oxidative and neutral hydrolytic conditions. Degradation behavior was studied by applying factorial design. Degradation profile was best described by quadratic models. Implementation of DoE approach enables the analyst to obtain desired levels of response.
